Literature DB >> 20880829

Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report.

Eiji Kirino1.   

Abstract

We present the case of a fifteen-year-old adolescent male with schizophrenia who had long-term catatonic stupor and was successfully treated with aripiprazole. The onset of his stupor manifested rapidly after experiencing prodromal symptoms for two months. He was left untreated without adequate food ingestion for three weeks because of his parents' religious faith, and was severely dehydrated and malnourished upon admission to our hospital. After his physical recovery, treatment with risperidone (0.5-2.0 mg, 5 weeks) was started. However, hypersedation occurred, and the risperidone was switched to aripiprazole, with dose increases up to 18 mg/day (5 months). As a result, he recovered from his totally noncommunicative state. Aripiprazole, which has a unique pharmacological mechanism of action distinct from other atypical antipsychotics and an excellent safety profile, may be effective in the treatment of some schizophrenic patients with stupor, which sometimes carries a risk of physical debilitation and requires special attention due to the risk of adverse drug reactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880829     DOI: 10.3371/CSRP.4.3.5

Source DB:  PubMed          Journal:  Clin Schizophr Relat Psychoses        ISSN: 1935-1232


  8 in total

Review 1.  [Pharmacotherapy of psychiatric acute and emergency situations: General principles].

Authors:  T Messer; F-G Pajonk; M J Müller
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

Review 2.  [Psychopharmacotherapy in emergency medicine].

Authors:  A Wolf; M J Müller; F-G B Pajonk
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-11       Impact factor: 0.840

3.  Treatment of refractory catatonic schizophrenia with low dose aripiprazole.

Authors:  Tsuyoshi Sasaki; Tasuku Hashimoto; Tomihisa Niitsu; Nobuhisa Kanahara; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2012-05-03       Impact factor: 3.455

Review 4.  Efficacy and safety of aripiprazole in child and adolescent patients.

Authors:  Eiji Kirino
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-03-25       Impact factor: 4.785

5.  Adolescent catatonia successfully treated with Lorazepam and aripiprazole.

Authors:  Aaron J Roberto; Subhash Pinnaka; Abhishek Mohan; Hiejin Yoon; Kyle A B Lapidus
Journal:  Case Rep Psychiatry       Date:  2014-08-12

Review 6.  Atypical antipsychotics in the treatment of early-onset schizophrenia.

Authors:  Michal Hrdlicka; Iva Dudova
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-01       Impact factor: 2.570

7.  Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases.

Authors:  Katsumasa Muneoka; Nobuhisa Kanahara; Shou Kimura
Journal:  SAGE Open Med Case Rep       Date:  2017-02-08

8.  Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients.

Authors:  Bunta Yoshimura; Tomoya Hirota; Manabu Takaki; Yoshiki Kishi
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-10       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.